STOCK TITAN

Vita Coco CFO Corey Baker sells 5,000 shares at $65

Four listed non-qualified option positions are reported with separate exercise prices and expiration dates.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Vita Coco Company, Inc. Chief Financial Officer Corey Baker exercised options for 5,000 common shares at $16.91 on November 4, 2026, and sold those 5,000 shares at $65 per share that day. He also sold 1,000 shares at $60 per share on November 3, 2026. Both sales were made under a Rule 10b5-1 trading plan.

Insider BAKER COREY
Role Chief Financial Officer
Sold 6,000 shs ($385K)
Approx. gross sale proceeds $385K
Approx. exercise cost $85K
Share of Position Sold 19.4%
Type Security Shares Price Value
Exercise Non-Qualified Stock Option (Right to Buy) F2 5,000 $0.00 $0.00
Exercise Common Stock 5,000 $16.91 $85K
Sale Common Stock F1 5,000 $65.00 $325K
Sale Common Stock F1 1,000 $60.00 $60K
Holding Non-Qualified Stock Option (Right to Buy) F3 -- -- --
Holding Non-Qualified Stock Option (Right to Buy) F4 -- -- --
Holding Non-Qualified Stock Option (Right to Buy) F3 -- -- --
Holding Non-Qualified Stock Option (Right to Buy) F5 -- -- --
Holdings After Transaction: Non-Qualified Stock Option (Right to Buy) — 51,197 contracts for 46,992 underlying shares (Direct); Common Stock — 24,951 shares (Direct)
Holdings Before and After: Non-Qualified Stock Option (Right to Buy), 56,197 to 51,197 contracts (Direct); Common Stock, 25,951 to 24,951 shares (Direct)
Footnotes (5)
  1. F1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2. The stock option vests in four equal annual installments beginning on March 10, 2024.
  3. F3. The stock option is vested as to 40% and will vest the remaining 30% on March 10, 2025, 20% on March 10, 2026 and 10% on March 10, 2027.
  4. F4. The stock option vests in four equal annual installments beginning on March 4, 2025.
  5. F5. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
Shares acquired through option exercise 5,000 shares November 4, 2026
Option exercise price $16.91 per share November 4, 2026
Shares sold and sale price 5,000 shares at $65 per share November 4, 2026
Shares sold and sale price 1,000 shares at $60 per share November 3, 2026
Underlying shares in listed option position 13,481 shares; $24.35 exercise price; expiration May 10, 2033 November 3, 2026
Underlying shares in listed option position 8,746 shares; $26.18 exercise price; expiration March 4, 2034 November 3, 2026
Underlying shares in listed option position 11,547 shares; $27.59 exercise price; expiration August 7, 2033 November 3, 2026
Underlying shares in listed option position 13,218 shares; $33.36 exercise price; expiration March 4, 2035 November 3, 2026
Rule 10b5-1 trading plan regulatory
"effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Non-Qualified Stock Option (Right to Buy) financial
"Non-Qualified Stock Option (Right to Buy)"
equal annual installments financial
"vests in four equal annual installments"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did COCO CFO Corey Baker sell, and at what prices?

Corey Baker sold 5,000 shares at $65 per share on November 4, 2026, and 1,000 shares at $60 per share on November 3, 2026; both sales were made under a Rule 10b5-1 trading plan.

What COCO option positions are listed for Corey Baker?

The reported direct non-qualified stock-option positions covered 13,481 underlying shares at a $24.35 exercise price, expiring May 10, 2033; 8,746 at $26.18, expiring March 4, 2034; 11,547 at $27.59, expiring August 7, 2033; and 13,218 at $33.36, expiring March 4, 2035.

What were the vesting terms for the option Corey Baker exercised?

The option exercised on November 4, 2026, vests in four equal annual installments beginning March 10, 2024.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BAKER COREY

(Last)(First)(Middle)
111 5TH AVENUE
2ND FLOOR

(Street)
NEW YORK NEW YORK 10003

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/03/2026S(1)1,000D$6024,951D
Common Stock11/04/2026M5,000A$16.9129,951D
Common Stock11/04/2026S(1)5,000D$6524,951D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-Qualified Stock Option (Right to Buy)$16.9111/04/2026M5,000 (2)03/10/2033Common Stock5,000$04,205D
Non-Qualified Stock Option (Right to Buy)$24.35 (3)05/10/2033Common Stock13,48113,481D
Non-Qualified Stock Option (Right to Buy)$26.18 (4)03/04/2034Common Stock8,7468,746D
Non-Qualified Stock Option (Right to Buy)$27.59 (3)08/07/2033Common Stock11,54711,547D
Non-Qualified Stock Option (Right to Buy)$33.36 (5)03/04/2035Common Stock13,21813,218D
Explanation of Responses:
1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
2. The stock option vests in four equal annual installments beginning on March 10, 2024.
3. The stock option is vested as to 40% and will vest the remaining 30% on March 10, 2025, 20% on March 10, 2026 and 10% on March 10, 2027.
4. The stock option vests in four equal annual installments beginning on March 4, 2025.
5. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
/s/ Alison Klein, Attorney-in-Fact for Corey Baker11/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading